Key Takeaways
- Shares fell approximately 5.4% on Monday, reaching a 52-week low of $14.62
- CEO Sean Connolly will depart May 31 after a decade in the role; John Brase assumes leadership June 1
- Third-quarter earnings per share of $0.39 fell short of the $0.40 Wall Street estimate
- Wall Street firms reduced price targets across the board; average target now stands at $16.07 with a “Reduce” consensus
- The company’s dividend yield approaches 9.8%, but a negative payout ratio threatens its long-term viability
Conagra Brands experienced another challenging session Monday, with shares tumbling roughly 5.4% to establish a fresh 52-week bottom at $14.62. Trading activity surged, with close to 2 million shares traded during the session.
The sharp decline followed a major corporate announcement regarding executive leadership. Sean Connolly, who has steered the company as CEO for ten years, will step down effective May 31. The board has appointed John Brase to succeed him, with his tenure beginning June 1.
Brase brings substantial industry experience to the position. His background includes serving as Chief Operating Officer at J.M. Smucker, along with senior-level positions at Procter & Gamble. Conagra confirmed he will simultaneously join the company’s board of directors.
Wall Street Responds With Caution
BofA Securities maintained its Underperform stance on CAG stock while holding its $15 price target steady. The firm characterized the leadership transition’s timing as unexpected and highlighted multiple challenges awaiting the new CEO.
Chief among these concerns: inflationary pressures that eroded earnings per share during fiscal 2026 and threaten to constrain fiscal 2027 performance. BofA emphasized the dividend payout ratio, which exceeds 80% — substantially higher than the company’s stated 50–55% target range.
The company’s net debt to EBITDA ratio currently stands at 3.8x. BofA raised the possibility of strategic divestitures to improve the balance sheet, specifically mentioning Hebrew National and Odom’s Tennessee Pride as brands previously discussed in asset sale conversations.
Deutsche Bank reduced its price objective to $14 while maintaining a Hold rating. JPMorgan and Stifel each lowered their targets to $17. UBS slashed its target from $20 to $16, citing margin compression and uncertainty surrounding fiscal 2027 prospects.
Wall Street’s overall rating currently stands at “Reduce” — consisting of 1 Buy, 12 Hold, and 4 Sell recommendations — with a mean price target of $16.07.
Disappointing Quarterly Results Added to Concerns
The company disclosed its third-quarter financial performance on April 1. Earnings per share registered at $0.39, missing the consensus forecast of $0.40 by a penny. Revenue totaled $2.79 billion, surpassing projections of $2.76 billion, though sales declined 1.9% compared to the prior-year period.
The same quarter last year saw the company deliver $0.51 in EPS — representing a significant deterioration. Net margin currently registers in negative territory at -0.39%, while the price-to-earnings ratio stands at -142.54.
Organic sales advanced 2.4% during the quarter, supported by a 0.5% uptick in volume and a 1.9% boost from pricing and product mix. However, margins disappointed expectations, and reduced equity income from Ardent Mills pressured profitability.
Management tightened its fiscal 2026 outlook following the release. Wall Street analysts are currently modeling full-year earnings per share of $2.35.
CAG’s 50-day moving average rests at $17.52, with the 200-day moving average at $17.60 — the stock trades substantially beneath both technical benchmarks. Shares have declined approximately 37% over the trailing twelve months and are down roughly 10.6% since the start of the year.
The quarterly dividend payment of $0.35 per share will be distributed June 3 to shareholders of record as of April 30. Based on current trading levels, this equates to an annualized dividend yield of approximately 9.8%.
